Here’s a shocking truth: Canada is a global pioneer in obesity care guidelines, yet Canadians are still waiting months—even years—for the very treatments we’ve championed. But here’s where it gets controversial: while the World Health Organization (WHO) now urges other countries to adopt our model, Canadians themselves are left behind, struggling to access the care they need. Why is this happening, and what can we do about it?
Canada’s leadership in obesity care is undeniable. Our 2020 clinical guidelines (https://doi.org/10.1503/cmaj.191707) redefined obesity as a chronic, relapsing disease requiring lifelong, comprehensive care—a model the WHO recently endorsed in its first-ever guideline on anti-obesity medications (https://www.who.int/news-room/events/detail/2025/12/01/default-calendar/from-evidence-to-action--who-guideline-on-the-use-of-glucagon-like-peptide-1-%28glp-1%29-therapies-for-the-treatment-of-obesity-in-adults). This approach includes timely diagnosis, coordinated care among health professionals, mental health support, and, when necessary, pharmacotherapy and bariatric surgery. Yet, despite this groundbreaking work, progress at home has been painfully slow.
And this is the part most people miss: more than one in four Canadian adults live with obesity (https://publications.gc.ca/collections/collection2025/aspc-phac/HP35-188-2024-eng.pdf?utmsource=copilot.com), and wait times for specialist care have skyrocketed to a staggering 30 weeks (https://www.fraserinstitute.org/sites/default/files/2024-12/waiting-your-turn-2024-newsrelease-natl.pdf). Worse, obesity disproportionately affects those facing social and economic disadvantages, widening health inequities. So, when will Canadians see this research translated into action?
Obesity touches every Canadian, directly or indirectly. Yet, it’s still widely misunderstood as a mere lack of willpower, solvable through diet and exercise alone. Here’s the bold truth: decades of evidence (https://doi.org/10.1093/nutrit/nuae144) prove obesity is a complex chronic disease influenced by biology, environment, and genetics. It’s linked to over 200 health conditions globally (https://obesitycanada.ca/understanding-obesity/health-impacts/#:%7E:text=The%20ripple%20effect%20of%20obesity,better%20care%20and%20improved%20outcomes.) and contributes to 3.7 million deaths annually. Still, most healthcare systems, including Canada’s, cling to outdated, weight-centric approaches instead of holistic, chronic disease models.
Canada has invested millions in obesity research (https://webapps.cihr-irsc.gc.ca/decisions/p/main.html?lang=en#fq=%7B!tag=allText%7DacallText%3Aobesity&sort=namesort%20asc&start=0&rows=20), producing cutting-edge, science-backed solutions. Yet, system-wide implementation is glacially slow. Why? Limited resources, inconsistent insurance coverage, and a lack of prioritization for comprehensive obesity care are to blame. Even clinicians eager to adopt evidence-based models often face barriers like inadequate training and fragmented systems.
The Canadian paradox: We’ve become a global leader in obesity care guidelines, but access at home remains patchy and inequitable. Over the past five years, Canadian experts have reshaped international standards (https://doi.org/10.1111/obr.13520), emphasizing patient-centered care focused on quality of life, function, and complication reduction—not just weight loss. Countries like Ireland and Chile have adopted our model, yet Canadians are still stuck in a system that fails to deliver.
Take the 2020 adult guideline (http://doi.org/10.1503/cmaj.191707), which moved beyond BMI as the sole measure of success. This stigma-free, patient-focused approach (https://obesitycanada.ca/healthcare-professionals/adult-clinical-practice-guideline/) has been adapted globally, but Canadians face barriers like limited public coverage for anti-obesity medications and wait times for bariatric surgery stretching up to nine years (https://obesitycanada.ca/wp-content/uploads/2019/05/OC-Report-Card-2019-English-Final.pdf).
Recent updates in 2025 further advanced the model. A pediatric guideline (https://doi.org/10.1503/cmaj.241456) emphasized family-centered care addressing mental health and cardiometabolic risks, while an adult pharmacotherapy update (https://obesitycanada.ca/wp-content/uploads/2025/08/11-Canadian-Adult-Obesity-CPG-Pharmacotherapy-2025-update.pdf) advocated for individualized use of medications like semaglutide and tirzepatide. Yet, these innovations remain out of reach for most Canadians.
Here’s a thought-provoking question: If Canada’s guidelines are so effective, why aren’t we prioritizing their implementation at home? Alberta took a step forward in 2025 by recognizing obesity as a chronic disease (https://www.globenewswire.com/news-release/2025/03/04/3036149/0/en/Alberta-Declares-March-4-as-World-Obesity-Day-Recognizing-Obesity-as-a-Chronic-Disease.html), but no pan-Canadian policy framework exists. Without coordinated action, patients are left navigating a fragmented system.
To fix this, we need bold changes. First, all provinces must recognize obesity as a chronic disease, unlocking comprehensive care options. A federal-provincial-territorial framework should implement our guidelines, prioritizing quality of life, mental health, and complication reduction. Finally, public and private insurance plans must cover anti-obesity medications, just as they do for diabetes care.
Canada’s global impact on obesity care is undeniable, but our success abroad highlights a glaring failure at home. If we don’t act now, lives will continue to be at stake, and obesity rates will keep climbing. What do you think? Is it time for Canada to practice what it preaches? Let’s start the conversation in the comments.
